Immunogenicity of SARS‐CoV‐2 vaccination in adolescents with cardiac disease

Hiroki Hayashi, Jun Narita,Ryo Ishii,Masaki Hirose,Kazuhisa Hashimoto,Yoshiaki Yamagishi,Keiichi Ozono,Hironori Nakagami,Hidekazu Ishida

Pediatrics International（2022）

引用 0|浏览2

暂无评分

摘要

SARS-CoV-2 mRNA vaccine has efficient immunogenicity for adolescents with CHD, IPAH, and DCM. Half of post-HTx patients could not acquire sufficient humoral immunity.

查看译文

关键词

COVID-19,SARS-CoV-2,antibody,congenital heart disease,quantiferon

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要